- Country: Ukraine
- Summary: L-Lysine Escinat, Solution for Injection, 1 Mg/Ml, 5 Ml; Ambroxol Syrup, 15 Mg/5 Ml 100 Ml; Ambroxol Syrup, 30 Mg/5 Ml 100 Ml; Arginine Glutamate Solution for Infusions, 8 Mg/Ml of 250 Ml; Ascorbic Ki ...
- UAT Ref No: 117542299
- Deadline: 15 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 545648
- Notice Type: Tender
- Document Ref. No.: UA-2025-04-10-006463-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- L-lysine escinat, solution for injection, 1 mg/ml, 5 ml; Ambroxol syrup, 15 mg/5 ml 100 ml; Ambroxol syrup, 30 mg/5 ml 100 ml; Arginine glutamate solution for infusions, 8 mg/ml of 250 ml; Ascorbic acid solution for injection, 50 mg/ml of 2 ml; Potassium asparaginate/magnesium asparaginate solution for injection5 ml; Clopidogrel, tablets covered with a shell, 75 mg; Atorvastatin, tablets, 40 mg; Brilliant green solution for external use, alcohol 1 %, 20 ml; Validol tablets of 60 mg; Vitamin B1/B6/B12, injection solution, 50 mg/50 mg/0.5 mg/1 ml, 2 ml; L-ornin/L-assetconcentrate for infusion solution, 500 mg/ml 10 ml; Decamethoxin, solution, 0.2 mg/ml, 400 ml; Deketoprofen solution for injection of 25 mg/ ml of 2 ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml; Lipoic acid solution for infusions, 30 mg/ml of 20 ml; Uralupidil solution for injection of 5 mg/ml on5 ml; Carbetocin solution for injection 100 μg/ml; Ketorolac solution for injection, 30 mg/ml, 1 ml; Quercetin lyophilizate for solution for injection of 0.5 g; Sodium baenzoate caffeine, injection solution, 100 mg/ml, 1 ml; Chloramphenicol/methyluracil ointment 7.5 mg/40 mg for 40 g; Balsamic liniment forVyshevsky 40 gr; Nicotinic acid solution for injection 10 mg/ml of 1 ml; Octreotide solution for injection 0.1 mg/ml of 1 ml; Papaverine, injection solution, 20 mg/ml, 2 ml; Hydrogen peroxide, solution, 3%, 100 ml; Pyridoxine (vitamin B6), solution for injection, 50 mg/ml, 1 ml; Platifyilin solutionFor ...
Purchase type: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
L-lysine escinate, solution for injection, 1 mg/ml, 5 ml, ambroxol syrup, 15 mg/5 ml 100 ml 100 ml, ambroxol syrup, 30 mg/mg. mg/ml of 250 ml, ascorbic acid solution for injection,50 mg/ml of 2 ml, potassium asparaginate/magnesium asparaginate solution for injection of 5 ml, clopidogrel, tablets covered with a shell, 75 mg, atorvastatin, tablets, 40 mg, brilliant green solution for external use, Basolamine 1... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINL-Lysine Escinat, Solution for Injection, 1 Mg/Ml, 5 Ml; Ambroxol Syrup, 15 Mg/5 Ml 100 Ml; Ambroxol Syrup, 30 Mg/5 Ml 100 Ml; Arginine Glutamate Solution for Infusions, 8 Mg/Ml of 250 Ml; Ascorbic Ki ... - Ukraine Tender
The THE MUNICIPAL NON -PROFIT ENTERPRISE OF THE DUNAEVTSI CITY COUNCIL "DUNAEVETSK MULTIDISCIPLINARY HOSPITAL, a Government sector organization in Ukraine, has announced a new tender for L-Lysine Escinat, Solution for Injection, 1 Mg/Ml, 5 Ml; Ambroxol Syrup, 15 Mg/5 Ml 100 Ml; Ambroxol Syrup, 30 Mg/5 Ml 100 Ml; Arginine Glutamate Solution for Infusions, 8 Mg/Ml of 250 Ml; Ascorbic Ki .... This tender is published on UkraineTenders under UAT Ref No: 117542299 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-15.
The estimated tender value is UAH 545648, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
